Nolicin (Norfloxacin)

Norfloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes required for DNA supercoiling and replication. Inhibiting these targets halts bacterial DNA synthesis, leading to bacterial cell death and a broad‑spectrum antibacterial effect.

The dosage of Nolicin is determined by the prescribing clinician based on the infection type, severity, patient age, renal function and other clinical factors. Patients should follow the prescriber’s instructions and not alter the dose on their own.

Safety of Norfloxacin during pregnancy and lactation has not been established. Because potential risks cannot be ruled out, the drug is generally avoided in pregnant or breastfeeding women unless the benefits outweigh the risks and no safer alternative is available.

To order Nolicin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Noricloxacin shares the same class mechanism as ciprofloxacin and levofloxacin but differs in its antimicrobial spectrum and pharmacokinetic profile. It is often chosen for infections where it demonstrates superior activity, such as certain urinary pathogens, while other fluoroquinolones may be preferred for respiratory or skin infections.

Store Nolicin at room temperature, below 25 °C, in the original blister or bottle. Keep the product away from moisture, direct sunlight and excessive heat. Do not use if the packaging is damaged or the tablets appear discoloured.

Nolicin is taken orally, usually with a full glass of water. It can be taken with or without food, but patients should avoid concurrent intake of antacids or supplements containing magnesium, aluminium or calcium, as these may reduce absorption.

Serious adverse events include tendon rupture (especially Achilles), peripheral neuropathy, QT‑interval prolongation leading to cardiac arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis and hepatic injury. Patients should seek immediate medical attention if they experience any of these symptoms.

Nolicin should be avoided in individuals with known hypersensitivity to Norfloxacin or other fluoroquinolones, in pregnant or breastfeeding women unless absolutely necessary, in children and adolescents for most indications, and in patients with a history of tendon disorders or significant cardiac QT prolongation.